Depression in type 1 diabetes was associated with high levels of circulating galectin-3

Endocrine Connections
Eva O MelinMagnus Hillman

Abstract

Neuroinflammatory responses are implicated in depression. The aim was to explore whether depression in patients with type 1 diabetes (T1D) was associated with high circulating galectin-3, controlling for metabolic variables, s-creatinine, life style factors, medication and cardiovascular complications. Cross-sectional. Participants were T1D patients (n = 283, 56% men, age 18-59 years, diabetes duration ≥1 year). Depression was assessed by Hospital Anxiety and Depression Scale-depression subscale. Blood samples, anthropometrics and blood pressure were collected, and supplemented with data from medical records and the Swedish National Diabetes Registry. Galectin-3 ≥2.562 µg/l, corresponding to the 85th percentile, was defined as high galectin-3. Median (quartile1, quartile3) galectin-3 (µg/l) was 1.3 (0.8, 2.9) for the 30 depressed patients, and 0.9 (0.5, 1.6) for the 253 non-depressed, P = 0.009. Depression was associated with high galectin-3 in all the 283 patients (adjusted odds ratio (AOR) 3.5), in the 161 men (AOR 3.4), and in the 122 women (AOR 3.9). HbA1c, s-lipids, s-creatinine, blood pressure, obesity, smoking, physical inactivity, cardiovascular complications and drugs (antihypertensive, lipid lowering, oral antidiabeti...Continue Reading

References

Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Sep 21, 2000·Kidney International. Supplement·F PricciG Pugliese
Dec 1, 2005·Trends in Immunology·Charles L RaisonAndrew H Miller
Mar 1, 2007·Diabetes Care·Katarina Eeg-OlofssonUNKNOWN Steering Committee of the Swedish National Diabetes Register
May 8, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Piotr MichalukLeszek Kaczmarek
Jan 19, 2010·The Journal of Clinical Endocrinology and Metabolism·Johanna WeigertChrista Buechler
Jan 12, 2012·Biochemistry Research International·Hiroyuki MizoguchiToshitaka Nabeshima
Aug 4, 2012·Journal of Affective Disorders·Janusz K RybakowskiJacek Losy
Sep 4, 2012·Journal of the American College of Cardiology·Jennifer E HoDaniel Levy
Jul 5, 2013·American Journal of Alzheimer's Disease and Other Dementias·Xuexin WangShouwei Yue
Oct 5, 2013·Archives of Cardiovascular Diseases·Nataliya HrynchyshynFrançois Funck
Nov 20, 2014·The New England Journal of Medicine·Marcus LindAnnika Rosengren
Aug 10, 2016·International Journal of Cardiology·A Rogier van der VeldeRudolf A de Boer

❮ Previous
Next ❯

Citations

Dec 19, 2019·Diabetic Medicine : a Journal of the British Diabetic Association·E van DuinkerkenM de Wit
May 28, 2020·Biomolecules·Ivan SrejovicGvozden Rosic
Sep 15, 2020·Journal of Neuroimmunology·Megan K LowtherE Sherwood Brown

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

Affect School with Script Analysis

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.